|Articles|September 1, 1998

Clinical and Economic Considerations of Epilepsy and Its Medical Management
Volume 4
Issue 9 Suppl

Vagus Nerve Stimulation

Author(s)Gershon Ney, MD

Download PDF: Vagus Nerve Stimulation

Articles in this issue

almost 28 years ago

Article

Participating Faculty

almost 28 years ago

Article

Medical Management of Epilepsy: Issues and Implications

almost 28 years ago

Article

Demographics and Cost of Epilepsy

almost 28 years ago

Article

Anticonvulsants: Choices and Costs

almost 28 years ago

Article

Care of Children With Epilepsy

almost 28 years ago

Article

Referral Centers and Specialized Care

almost 28 years ago

Article

Determining Costs and Cost-Effectiveness of Epilepsy

almost 28 years ago

Article

Selected Abstracts

almost 28 years ago

Article

CME Quiz

almost 28 years ago

Article

Bibliography

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

Vagus Nerve Stimulation

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

US Employer Health Care Costs Projected to Rise 9.5% in 2027

Student Mental Health, Success Tied to Future Health and Affordability

Rural Patients Face Gaps in Hospice Access, Care Intensity

FDA Approves First Orexin Agonist for Narcolepsy Type 1